Effect of a 12-month Pharmaceutical Care Program on Control of Severe Asthma

Not Applicable

Completed

• Conditions: Asthma; Quality of Life

• Registration Number: NCT01644357
• Lead Sponsor: Federal University of Bahia

Brief Summary

Only a few well-designed studies have investigated the effect of pharmaceutical care on asthma patients and to date there are no published studies investigating this effect specifically on severe and refractory asthma.

The objective of this study is evaluate the effect of pharmaceutical care on asthma control and quality of life (QoL) of patients with severe or refractory asthma compared with pharmacist dispensation only.

Detailed Description

Not available

Study Timeline

• Study Start: 2008-08
• Primary Completion: 2011-08
• Study First Submitted: 2012-07-17
• Study First Submitted QC: 2012-07-18
• Study First Posted: 2012-07-19
• Study Completion: 2014-07
• Status Verified: 2023-09
• Last Update Submitted: 2023-09-11
• Last Update Posted: 2023-09-13

Recruitment & Eligibility

• Status: COMPLETED
• Sex: All
• Target Recruitment: 40

Inclusion Criteria

• Patients with severe/refractory asthma presenting other respiratory disease,
• ≥ 18 years of age,
• using high dose of inhaled corticosteroids (≥ 800mcg of budesonide or equivalent)
• FEV1<60%,
• regular visitor of the pharmacy and the physicians.

Exclusion Criteria

• participation in other intervention study during this study,
• living in other cities,
• could not participate in all visits of the study

Study & Design

• Study Type: INTERVENTIONAL
• Study Design: PARALLEL

Primary Outcome Measures

Name	Time	Method
asthma control of symptoms	12 months	Measured by Asthma Control Questionnaire and medical evaluation

Trial Locations

Locations (1)

Program for Asthma Control (ProAR) of the Federal University of Bahia; 🇧🇷 Salvador, Bahia, Brazil